- abnormal spleen morphology / IMPC
- abnormal sternum morphology / IMPC
- small uterus / IMPC
- enlarged heart / IMPC
- abnormal iris morphology / IMPC
- limb grasping / IMPC
- enlarged adrenal glands / IMPC
- decreased circulating aspartate transaminase level / IMPC
- abnormal gait / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- cataract / IMPC
- abnormal auditory brainstem response / IMPC
- enlarged urinary bladder / IMPC
- aspermia / IMPC
- abnormal eye morphology / IMPC
- irregularly shaped pupil / IMPC
- hypoplasia / IMPC
- cataract / IMPC
- abnormal tooth morphology / IMPC
- follicular atresia / IMPC
- increased grip strength / IMPC
- abnormal embryo size / IMPC
- dysplasia / IMPC
- abnormal seminal vesicle morphology / IMPC
B6.129-Hsd17b4tm1Baes/Orl
| Status | Available to order |
| EMMA ID | EM:13783 |
| Citation information | RRID:IMSR_EM:13783 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | B6.129-Hsd17b4tm1Baes/Orl |
| Alternative name | HSD17B4 |
| Strain type | Targeted Mutant Strains : Knock-out |
| Allele/Transgene symbol | Hsd17b4tm1Baes |
| Gene/Transgene symbol | Hsd17b4 |
Information from provider
| Provider | Myriam Baes |
| Provider affiliation | Pharmaceutical and pharmacological sciences, KU Leuven |
| Genetic information | Hsd17b4 ((hydroxysteroid (17-beta) dehydrogenase 4) gene was amplified from P1 genomic library (donor strain not known). Targeting vector DNA (for recombinant removal of exon 1-3 of the Hsd17b4 gene) was transfected into R1 ES cells ((129X1/SvJ x 129S1/Sv)F1). |
| Phenotypic information | Homozygous:The first 3 exons of the mouse Hsd17b4 gene are removed by homologous recombination. As a result, no functional protein for MFP2 (Hsd17b4 or 17beta-HSD4) can be formed, and, an important central enzymatic reaction such as e.g. beta-oxidation of certain fatty acids, can no longer take place. Homozygous MFP2 knockout (MFP2 -/-) mice are born, but up to 30% of young MFP2 -/- mice can die prematurely after birth. The growth is delayed and the knockout animals never reach the weight and size of wild-type or heterozygous siblings. Females show impaired fertility. Males develop complete testis atrophy. MFP2-deficient mice accumulate very long chain fatty acids (VLCFA) in the brain, C27 bile acid intermediates in the bile, and phospholipids and branched chain fatty acids in the liver, due to impaired peroxisomal beta-oxidation of these substrates. In the MFP2 knockout brain, various anomalies can be detected, such as accumulation of neutral fats, overexpression of catalase and severe astro- and microgliosis. Some weeks after birth, the MFP2 knockout mice show limb cramping when lifted on the tail. Further, the animals develop diminished motor skills, which in turn leads to less mobility. The homozygous animals of the C57BL/6J line die between the age of 4 and 6 months.Heterozygous:Heterozygous MFP2 knock-out (MFP2 +/-) mice do not show a phenotype since the Hsd17b14 gene in these animals is switched off in only one allele and the wild-type gene of the other allele takes full function in the mouse. |
| Breeding history | Heterozygous Hsd17b4 mice were bred for at least 8 generations into C57BL/6J |
| References |
|
| Homozygous fertile | no |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | no |
Information from EMMA
| Archiving centre | CNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France |
| Animals used for archiving | heterozygous C57BL/6J males |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Perrault syndrome / Orphanet_2855
- Bifunctional enzyme deficiency / Orphanet_300
IMPC phenotypes (gene matching)
Literature references
- Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids.;Baes M, Huyghe S, Carmeliet P, Declercq P E, Collen D, Mannaerts G P, Van Veldhoven P P, ;2000;The Journal of biological chemistry;275;16329-36; 10748062
- Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice.;Huyghe Steven, Schmalbruch Henning, De Gendt Karel, Verhoeven Guido, Guillou Florian, Van Veldhoven Paul P, Baes Myriam, ;2006;Endocrinology;147;2228-36; 16484321
- Specific suppression of microgliosis cannot circumvent the severe neuropathology in peroxisomal β-oxidation-deficient mice.;Beckers L, Stroobants S, Verheijden S, West B, D'Hooge R, Baes M, ;2017;Molecular and cellular neurosciences;80;123-133; 28286294
- Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system.;Huyghe Steven, Schmalbruch Henning, Hulshagen Leen, Veldhoven Paul Van, Baes Myriam, Hartmann Dieter, ;2006;The American journal of pathology;168;1321-34; 16565505
- Early-onset Purkinje cell dysfunction underlies cerebellar ataxia in peroxisomal multifunctional protein-2 deficiency.;De Munter Stephanie, Verheijden Simon, Vanderstuyft Esther, Malheiro Ana Rita, Brites Pedro, Gall David, Schiffmann Serge N, Baes Myriam, ;2016;Neurobiology of disease;94;157-68; 27353294
- Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal β-oxidation deficiency.;Geric Ivana, Tyurina Yulia Y, Krysko Olga, Krysko Dmitri V, De Schryver Evelyn, Kagan Valerian E, Van Veldhoven Paul P, Baes Myriam, Verheijden Simon, ;2018;Immunology;153;342-356; 28940384
- Identification of a chronic non-neurodegenerative microglia activation state in a mouse model of peroxisomal β-oxidation deficiency.;Verheijden Simon, Beckers Lien, Casazza Andrea, Butovsky Oleg, Mazzone Massimiliano, Baes Myriam, ;2015;Glia;63;1606-20; 25846981
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
